Psychomotor Disorders
Psychomotor Disorders
Explore linked clinical trials. Standard reference: MESH:M001802673 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Wearable Sensor Toolkit for Infant Motor Development | Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Disorders, Signs and Symptoms, developmental disability, nervous system disorder, neurodevelopmental disorder, psychiatric disorder | Not yet recruiting | Not stated | 2026-10-08 | NCT07866495 | |
| A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease | Alzheimer disease, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 3 | 2026-10-08 | NCT07011745 | |
| Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type | Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-10-08 | NCT06052254 | |
| Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease | Alzheimer disease, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 2 | 2026-10-06 | NCT06808984 | |
| Decoding Death and Dying in People With Dementia by Digital Thanotyping | Death, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Respiration Disorders, Respiratory Aspiration, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, psychiatric disorder, respiratory system disorder | Enrolling by invitation | Not stated | 2026-10-01 | NCT06437132 | |
| Deep Brain Stimulation + Therapy for Stroke | Deglutition Disorders, Digestive System Diseases, Dysarthria, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Pharyngeal Diseases, Psychomotor Disorders, Signs and Symptoms, apraxia, articulation disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, communication disorder, digestive system disorder, esophageal disorder, language disorder, nervous system disorder, otorhinolaryngologic disease, speech disorder, stroke disorder, vascular disorder | Not yet recruiting | Not applicable | 2026-09-30 | NCT07849114 | |
| Clinical Trial on Agitation in Alzheimer's Dementia | Alzheimer disease, Chemically-Induced Disorders, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, anxiety disorder, brain disorder, cannabis dependence, central nervous system disorder, cognitive disorder, dementia, depressive disorder, nervous system disorder, neurodegenerative disease, psychiatric disorder, substance-related disorder, tauopathy | Active, not recruiting | Phase 2 | 2026-09-30 | NCT05543681 | |
| A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) | Alzheimer disease, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 3 | 2026-09-28 | NCT06937229 | |
| Neurosteer Bedside Monitoring System | Confusion, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, cognitive disorder, delirium, nervous system disorder, psychiatric disorder | Recruiting | Not applicable | 2026-09-28 | NCT06718764 | |
| Feasibility and Preliminary Effects of a Therapeutic Approach Using Ultrasound Visual Biofeedback in Children With AFI: a Pilot Randomized Clinical Trial. | Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Disorders, Signs and Symptoms, Speech Sound Disorder, apraxia, childhood apraxia of speech, communication disorder, nervous system disorder, neurodevelopmental disorder, psychiatric disorder | Recruiting | Not applicable | 2026-09-23 | NCT07087249 | |
| Motor-based Intervention for Childhood Apraxia of Speech: DTTC-Connect | Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Disorders, Signs and Symptoms, apraxia, childhood apraxia of speech, nervous system disorder | Recruiting | Not applicable | 2026-09-18 | NCT07526246 | |
| Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type | Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, nervous system disorder | Active, not recruiting | Phase 3 | 2026-09-15 | NCT05397639 | |
| Speech Therapy for Children With Rare Genetic Conditions and Childhood Apraxia of Speech | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Disorders, Signs and Symptoms, apraxia, childhood apraxia of speech, communication disorder, hereditary disease, nervous system disorder, neurodevelopmental disorder, psychiatric disorder | Recruiting | Not applicable | 2026-09-11 | NCT07815249 | |
| Goal-Directed Sedation in Mechanically Ventilated Infants and Children | Confusion, Critical Illness, Disease Attributes, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, Stress Disorders, Traumatic, acute stress disorder, cognitive disorder, delirium, nervous system disorder, post-traumatic stress disorder, psychiatric disorder | Active, not recruiting | Phase 3 | 2026-09-11 | NCT04801589 | |
| Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine Monotherapy for Hyperactive Delirium in ICU Patients on Non-Invasive Respiratory Support (SEED-NIRS Trial): Study Protocol of a Randomized Controlled Trial | Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, agnosia, nervous system disorder, perceptual disorders | Not yet recruiting | Phase 4 | 2026-09-03 | NCT07377981 | |
| A Multicomponent Intervention Program to Prevent and Reduce ICU Agitation and Physical Restraint Use | Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, nervous system disorder | Recruiting | Not applicable | 2026-08-20 | NCT05783505 | |
| Neural Mechanisms of Clinically Designed Improvisatory Music for Alzheimer's Disease | Alzheimer disease, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, anxiety disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Enrolling by invitation | Not applicable | 2026-08-10 | NCT05477862 | |
| Effect of Daily Screen Time on Postoperative Emergence Delirium in Children Aged 2-11 Years | Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, nervous system disorder | Recruiting | Not stated | 2026-08-05 | NCT07552896 | |
| Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Hypoxia, Hypoxia, Brain, Infant, Newborn, Diseases, Infant, Premature, Diseases, Lung Injury, Neurobehavioral Manifestations, Neurologic Manifestations, Obstetric Labor Complications, Obstetric Labor, Premature, Pathological Conditions, Signs and Symptoms, Premature Birth, Psychomotor Disorders, Signs and Symptoms, Signs and Symptoms, Respiratory, Urogenital Diseases, Ventilator-Induced Lung Injury, brain disorder, brain hypoxia - ischemia, brain ischemia, bronchopulmonary dysplasia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, lung disorder, nervous system disorder, perinatal asphyxia, pregnancy disorder, respiratory system disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-07-31 | NCT05568264 | |
| Role of Omega-DEK in Childhood Apraxia of Speech | Apraxia, Verbal, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Disorders, Signs and Symptoms, apraxia, autism, autism spectrum disorder, childhood apraxia of speech, nervous system disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder | Not yet recruiting | Phase 2 | 2026-07-29 | NCT07216001 | |
| Protocolized Receptive Music Intervention to Reduce Care Refusal in Nursing Home Residents With Major Neurocognitive Disorders | Burnout, Professional, Cognition Disorders, Cognitive Dysfunction, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Occupational Diseases, Occupational Stress, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, psychiatric disorder | Recruiting | Not applicable | 2026-07-28 | NCT07730957 | |
| Melatonin for Post Tonsillectomy Emergence Agitation in Pediatric | Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, nervous system disorder | Recruiting | Not applicable | 2026-07-17 | NCT07375342 | |
| Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients | Dyskinesias, Dyssomnias, Neurobehavioral Manifestations, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, Sleep Disorders, Intrinsic, anxiety disorder, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorder | Recruiting | Not applicable | 2026-06-22 | NCT07649876 | |
| Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia | Alzheimer disease, Apraxia, Motor, Dysarthria, Frontotemporal Lobar Degeneration, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Psychomotor Disorders, Signs and Symptoms, TDP-43 proteinopathy, aphasia, apraxia, articulation disorder, brain disorder, central nervous system disorder, cognitive disorder, communication disorder, dementia, frontotemporal dementia, language disorder, metabolic disease, nervous system disorder, neurodegenerative disease, neurodevelopmental disorder, primary progressive aphasia, proteostasis deficiencies, psychiatric disorder, speech disorder, tauopathy | Recruiting | Not applicable | 2026-06-10 | NCT05741853 | |
| Rapid Syllable Transition (ReST) Interventions for Speech Sound Disorders in Children | Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Disorders, Signs and Symptoms, apraxia, childhood apraxia of speech, communication disorder, nervous system disorder, neurodevelopmental disorder, psychiatric disorder | Active, not recruiting | Not applicable | 2026-06-09 | NCT07636031 |